South Africa Deems Astrazeneca Vaccine Inefficient for Variant Discontinues Use

South Africa has discontinued the use of AstraZeneca’s covid-19 vaccine after a study revealed that it falls short when treating the variant. The coronavirus mutation has taken predominance in the country prompting officials to halt what a Oxford University study revealed as a “substantial drop” in suppressing the variant.

Source: Francis Kokoroko/Reuters

“When we analyzed individuals in terms of how well the vaccine worked against the variant, there was very little difference between the vaccine group and placebo group and placebo group, said the studies leader, Shabir Madhi. While adding that covid-19 vaccines are the “only sustainable option of reducing risk of severe disease and death.”

South Africa tallied 2,435 new cases of the coronavirus on Sunday bringing it’s total infections to more than 1.47 million people and 46,290 deaths.


Published by